Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Non-Current Assets (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Non-Current Assets for 9 consecutive years, with $2.5 million as the latest value for Q3 2024.

  • Quarterly Non-Current Assets fell 14.33% to $2.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Sep 2024, down 7.17% year-over-year, with the annual reading at $3.0 million for FY2023, 4.39% down from the prior year.
  • Non-Current Assets for Q3 2024 was $2.5 million at SELLAS Life Sciences, down from $2.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $9.3 million in Q2 2020, with the low at $2.5 million in Q3 2024.
  • Average Non-Current Assets over 5 years is $5.3 million, with a median of $3.4 million recorded in 2022.
  • Peak annual rise in Non-Current Assets hit 11.02% in 2021, while the deepest fall reached 64.59% in 2021.
  • Over 5 years, Non-Current Assets stood at $9.1 million in 2020, then tumbled by 64.59% to $3.2 million in 2021, then decreased by 1.36% to $3.2 million in 2022, then fell by 4.39% to $3.0 million in 2023, then dropped by 18.94% to $2.5 million in 2024.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $2.5 million, $2.8 million, and $2.9 million for Q3 2024, Q2 2024, and Q1 2024 respectively.